MalariaGEN is a scientific network that connects researchers and clinicians in malaria-endemic countries with cutting-edge DNA sequencing technologies and genomic research. Through a number of multi-centre projects, we provide a framework for generating, integrating and sharing genetic and genomic data, and for investigating key questions about malaria biology and epidemiology.
| Website | https://www.malariagen.net/ |
| Revenue | $806000 |
| Employees | 2 (0 on RocketReach) |
| Founded | 2005 |
| Industry | Research, Business Services General, Business Services |
| Competitors | Roche, Novartis, Merck & Co., Inc., Pfizer, Sanofi, GSK, AstraZeneca, Bristol Myers Squibb, Broad Institute of MIT and Harvard, Wellcome Sanger Institute +45 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies |
Looking for a particular MalariaGEN employee's phone or email?
The MalariaGEN annual revenue was $806000 in 2026.
The NAICS codes for MalariaGEN are [5417, 54, 541713, 54171, 541].
The SIC codes for MalariaGEN are [873, 87].